Prakt. lékáren. 2005; 1(1): 16-17

Léčiva na bázi pyrazinu

doc. PharmDr. Martin Doležal Ph.D1,2
1 _
2 Farmaceutická fakulta, Hradec Králové

Synteticky připravené pyraziny jsou používány jako identická „vonidla“ či „chutidla“ v potravinářství, ve voňavkářství či v tabákovém průmyslu. Pyraziny mají celou škálu biologických účinků, používají se i jako důležitá léčiva. Historicky prvními byla sulfonamidová chemoterapeutika sulfapyrazin a jeho strukturní varianta sulfalen, velmi jednoduchým derivátem je stále významné antituberkulotikum pyrazinamid. Dalšími důležitými léčivy jsou kalium šetřící diuretikum amilorid, hypolipidemikum acipimox, perorální antidiabetikum glipizid či nebenzodiazepinové hypnotikum zopiklon. Z vyvíjených látek zaslouží pozornost potenciální antineoplastikum pyrazindiazohydroxid či zajímavé antivirotikum 6-fluor-3-hydroxypyrazin-2-karboxamid.

Keywords: Klíčová slova: pyrazin, chemická léčiva, vývoj léčiv.

Published: February 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doležal M. Léčiva na bázi pyrazinu. Praktické lékárenství. 2005;1(1):16-17.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. A-Rahim YI, Beyer KHJr, Vesell ES. Studies on pyrazinoylguanidine. 3. Downregulation of lipolysis in isolated adipocytes. Pharmacology 1996; 53: 197-210. Go to original source... Go to PubMed...
    2. Bergmann KE, Cynamon MH, Welch JT. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters. J. Med. Chem. 1996; 39: 3394-3400. Go to original source... Go to PubMed...
    3. Bird CW. Heteroaromaticity. 5. A unified aromaticity index. Tetrahedron 1992; 48: 335-340. Go to original source...
    4. Doležal M, Jampílek J, Osička Z, a kol. Substituted 5-aroylpyrazine-2-carboxylic acid derivatives: synthesis and biological activity. Il Farmaco 2003; 58: 1105-1111. Go to original source... Go to PubMed...
    5. Duffield RM, Blum MS, Wheeler JW. Alkylpyrazine alarm pheromones in primitive ants with small colonial units. Comp. Biochem. Physiol. B 1976; 54: 439-440. In: Chem. Abstr. 1976; 85: 14043w. Go to original source... Go to PubMed...
    6. Edelman MJ, Meyers FJ, Grennan T, a kol. Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer. Invest New Drugs. 1998; 16: 179-182. Go to original source... Go to PubMed...
    7. France CP, Winger G, Medzihradsky F, a kol. Mirfentanil - Pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects. J. Pharmacol. Exp. Ther. 1991; 258: 502-510. Go to original source...
    8. Furuta Y, Takahashi K, Fukuda Y, a kol. In vitro and in vivo activities of anti-influenza virus compound T-705 Antimicrob. Agents Chemother. 2002; 46: 977-981. Go to original source... Go to PubMed...
    9. Hocek M. Synthesis and biological activity of 2-and 6-C-substituted purine bases, nucleosides and acyclic nucleotide analogues. Chem. Listy 2002; 96: 978-982.
    10. Kessler FK, Ritter JK. Induction of a rat liver benzo[a]pyrene-trans-7,8-dihydrodiol glucuronidating activity by oltipraz and beta-naphthoflavone. Carcinogenesis 1997; 18: 107-114. Go to original source... Go to PubMed...
    11. Lee HS, Bastani B, Friedman L, a kol. Effect of the serotonin agonist, MK-212, on body temperature in schizophrenia. Biol. Psychiatry. 1992; 31: 460-470. Go to original source... Go to PubMed...
    12. Lüllmann H, Mohr K, Wehling M. Farmakologie a toxikologie. 1. české vydání Praha: Grada Publishing 2002: 696 s.
    13. Maga JA. Pyrazine update. Food Rev. Inter. 1992; 8: 479-558. Go to original source...
    14. McCullough KJ. Pyrazines and Related Ring Structures. In: Ansell MF. Rodd's Chemistry of Carbon Compounds. 2nd Edition, Vol. IV, Elsevier, New York, 1995: 93-130. Go to original source...
    15. Portnoy RCh. Arylthiodicyanopyrazines as plant disease control agents. U.S. 4, 113, 724 1978. In: Chem. Abstr. 1979; 90: P72233j.
    16. Prochaska HJ, Chavan SJ, Baron P, Polsky BJ. Oltipraz, a novel inhibitor of human-immunodeficiency-virus type1 (HIV-1) replication. Cell. Biochem. 1995; 22 Suppl.: 117-125. Go to original source... Go to PubMed...
    17. Tsai SJ, Jenq SN, Lee H. Naturally occurring diallyl disulfide inhibits the formation of carcinogenic heterocyclic aromatic amines in boiled pork juice. Mutagenesis 1996; 11: 235-240. Go to original source... Go to PubMed...
    18. Výzkumné záměry Ministerstva školství, mládeže a tělovýchovy ČR: MSM 0021620822.
    19. Woolfson A, Rothschild M. Speculating about pyrazines. Proc. Roy. Soc. Lond. Ser. B - Biol. Sci. 1990; 242: 113-119. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.